跳至主要内容
临床试验/ACTRN12619000442101
ACTRN12619000442101已完成未知

A randomised, cross-over, pilot trial investigating the effects of a novel renal dietary intervention (rich in plant foods, utilising a whole food dietary approach) designed to improve diet quality, symptom burden, the gastrointestinal microbiome and other health outcomes including biochemical markers in adults with moderate to severe chronic kidney disease.

niversity of Wollongong0 个研究点目标入组 28 人开始时间: 2019年3月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participants diagnosed with stage 3-4 CKD non-dialysing/ pre-dialysis (eGFR 15-59mL/min per 1.73m2) or individuals deemed suitable by the medical team (Nephrologist).
  • - Adults (aged 18 years old or more)
  • - Participants must be able to give informed consent; i.e. have no major cognitive or sensory impairment

排除标准

  • Individuals who are less than 18 years of age
  • Individuals with intellectual or mental impairment as well as those with a hearing impairment will only be excluded if they cannot follow safety simple instructions due to concerns relevant to the safety of the patient.
  • Individuals receiving dialysis
  • Individuals diagnosed with dysphagia and/or require texture modified diet
  • Any women who are found to be pregnant during the trial would need to be immediately excluded due to the increased medical demands of a pregnancy in kidney disease.
  • Individuals with past or present radiation to the bowel or large bowel resection
  • Individuals with advanced colorectal cancer
  • Individuals who consumed antibiotic therapy within 1 months of study commencement
  • Individuals with medically diagnosed irritable bowel syndrome, crohn’s disease or ulcerative colitis;
  • Individuals who have had a clinically significant change to their immunosuppressant dose within the last 6 months (determined by the medical team) of study commencement.

研究者

发起方
niversity of Wollongong

相似试验

尚未招募
1 期
A pilot study, crossover randomized control trial on effect of oral calcium carbonate to fecal functional levofloxacin concentration in healthy volunteer taking oral levofloxaciWe will study healthy volunteer if calcium carbonate can reduced functional fecal levofloxacin and protect fecal microbiome or not.1.Levofloxacin2.Calcium carbonate3.fecal functional level of levofloxacin4. Microbiota diversity5. Maximal plasma levofloxacin concentration(C max)
TCTR20210419003Royal College of Physician Thailand16
已完成
不适用
A randomised controlled pilot trial investigating the feasibility of monitoring patients with or at risk for cardiovascular disease who have symptoms suspected of COVID-19 by pulse oximetry at home
NL-OMON54917niversitair Medisch Centrum Utrecht50
招募中
不适用
A randomised controlled pilot trial investigating the feasibility of monitoring patients with or at risk for cardiovascular disease who have symptoms suspected of COVID-19 by pulse oximetry at home
NL-OMON25226MC Utrecht50
进行中(未招募)
1 期
A randomised, double blind, crossover pilot study of intravenous buprenorphine versus intravenous buprenorphine/ naloxone in patients with chronic pain.Chronic pain
EUCTR2007-000329-22-GBReckitt Benckiser Healthcare (UK) Limited30
已完成
不适用
VEgetableS for vaScular hEaLth: The VESSEL StudyBlood pressureGlycemic controlInflammationOxidative stressArterial stiffnessCardiovascular - Normal development and function of the cardiovascular systemMetabolic and Endocrine - Normal metabolism and endocrine development and functionInflammatory and Immune System - Normal development and function of the immune system
ACTRN12619001294145Edith Cowan University21